Skip to main navigation
Skip to search
Skip to main content
Rutgers, The State University of New Jersey Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Federal Grants
Research output
Search by expertise, name or affiliation
Stem Cell-based Platform for Targeted Enzyme/Prodrug Therapy of Recurrent Ovarian Cancer
Hatefi, Arash
(PI)
Ernest Mario School of Pharmacy, Pharmaceutics
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Enzyme Therapy
100%
Ovarian Neoplasms
87%
Prodrugs
86%
Stem Cells
66%
Neoplasms
38%
Recurrence
27%
Survival Rate
27%
Pharmaceutical Preparations
24%
human CES2 protein
23%
Standard of Care
23%
Survival
19%
TP protocol
17%
Immunohistochemistry
16%
Magnetic Resonance Imaging
15%
Tropism
14%
Irinotecan
14%
Ovarian Epithelial Carcinoma
13%
Hematology
12%
Neoplastic Stem Cells
12%
Platinum
12%
Therapeutics
11%
Tumor Burden
11%
Drug Resistance
11%
Ovary
10%
Clone Cells
9%
Technology
7%
Neoplasm Metastasis
7%
Drug Therapy
7%
Enzymes
6%
Mortality
6%